Description

This Clinical Simulation tests your clinical decision-making in the context of a real-world patient case. Access videos and case-based information that highlights challenging clinical presentations of depression associated with fatigue, and implement diagnostic and treatment strategies to manage the condition.

Fatigue frequently occurs in depression, but its importance as a leading cause of morbidity is largely underappreciated. While fatigue is easy to observe, it is difficult to characterize. It can be a prodromal symptom of depression or a core component of acute illness, yet it can also be a side effect of antidepressants, a result of sleep disturbance, or a residual symptom of depression. Consequences for patients are many, including increased severity of depression, decreased productivity, cognitive dysfunction, and increased risk of recurrence.

Learning Objectives

At the end of this educational activity, participants should be able to:

  • Identify and assess residual symptoms after antidepressant treatment in a simulated depressed patient.
  • Assess residual symptoms contrasting HAM-D and CPFQ standardized instruments.
  • Formulate a follow up treatment plan based on clinical presentation.

Target Audience

Psychiatrists, Psychologists, Primary Care Physicians, Nurse Practitioners, and Physician Assistants

Faculty

  • David Mischoulon, MD, PhD
    Director of Research, Depression Clinical and Research Program, MGH
    Associate Professor of Psychiatry, Harvard Medical School

CME Information

Release Date: December 14, 2012

Expiration Date: December 13, 2013

To receive credit for this activity, listen to the presentation and complete the evaluation.

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of McLean Hospital and Massachusetts General Hospital. McLean Hospital is accredited by the ACCME to provide continuing medical education (CME) for physicians.


McLean Hospital designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

________________________________________

Credit Designation 

Psychologists: The Massachusetts General Hospital Department of Psychiatry is approved by the American Psychological Association to sponsor continuing education for psychologists. The Massachusetts General Hospital Department of Psychiatry maintains responsibility for this program and its content. This offering meeting the criteria for 1 Continuing Education (CE) credit per presentation for psychologists.

Nurses: This program meets the requirements of the Massachusetts Board of Registration in Nursing (224 CMR 5.00) for 1 contact hour of nursing continuing education credit.

________________________________________

Policy on Faculty and Provider Disclosure

It is the policy of McLean Hospital that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity. McLean Hospital has established policies in place that identify and resolve all conflicts of interest prior to this educational activity.

________________________________________

Planner Disclosures

The following planners of this activity have indicated that neither they nor their spouse/partner have a relevant financial relationship to disclose:

Robert J. Birnbaum, MD, reviewer

John A. Fromson, MD

Tristan Gorrindo, MD

Anan Nathif, EdM

________________________________________

Speaker Disclosures

The following speakers of this activity have indicated that they or their spouse/partner do have a relevant financial relationship to disclose:

David Mischoulon, MD, PhD

Research Support:

Nordic Naturals, Ganeden, FisherWallace, Bowman Family Foundation

Speaking:

Nordic Naturals, MGH Psychiatry Academy

Royalty:

Lippincott Williams & Wilkins ("Natural Medications for Psychiatric Disorders: Considering the Alternatives" (David Mischoulon and Jerrold F. Rosenbaum, Eds.)

________________________________________

We are committed to giving learners the most comprehensive view of disclosure information. For this reason, in addition to listing the disclosures specific to this activity, we also maintain a database of global disclosures for all faculty who plan or speak at our activities. Biographical information for each facutly is also included. To view a specific speaker or planner’s global disclosure, please click on the appropriate link below.

David Mischoulon, MD, PhD

________________________________________

Supporters:

  • Lilly
  • Dey
  • PamLab
  • Genomind

________________________________________

Hardware/Software Specifications: 

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player. 

Optimal System Configuration: 

Flash Player: Adobe Flash Player 10.1+ 

Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+ 

Operating System: Windows XP+ or Mac OS X 10.4+ 

Internet Connection: 1 Mbps or higher

Minimum Requirements: 

Windows PC:

500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera 

Macintosh:

Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit


Supporters

This program has received support in the form of educational grants from the following companies: